# The Cigna (CI) — Earnings

CI · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/ci/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $7.78 |
| EPS estimate | $7.60 |
| EPS surprise | +2.42% |
| Revenue surprise | +2.17% |
| Revenue | $71.7B |
| Revenue estimate | $70.1B |
| Reported | Jul 30, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1739940/000173994026000065/ci-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/16d1b27e-126c-d316-6089-d70b50c5b857.html) |

Cigna reported Q2 2026 results on July 30, 2026. Earnings per share came in at $7.78, ahead of the $7.60 estimate by 2.42%. Revenue was $71.7 billion, 2.17% above the $70.1 billion consensus. Compared with Q2 2025, EPS rose about 8% from $7.20 and revenue rose about 7% from $67.1 billion.

The longer record shows steady growth. Annual EPS rose from $23.23 in 2022 to $25.10 in 2023, $27.34 in 2024 and $29.85 in 2025. Revenue grew faster, from about $181 billion in 2022 to about $275 billion in 2025, a gain of roughly 52%. The first half of 2026 added $15.57 per share, about 12% more than the same period a year earlier. Q4 2025 set the highs in the table, at $8.08 per share and $72.5 billion in revenue. Over the last 20 quarters, Cigna topped the EPS estimate 19 times. The only miss was Q4 2024, at 15.17% below.

Cigna reported Q3 between October 30 and November 4 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the year-over-year growth seen in the first half carries into the third quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 30, 2026 | $7.60 | $7.78 | 2.42% | $70.1B | $71.7B |
| Q1 2026 | Apr 30, 2026 | $7.60 | $7.79 | 2.52% | $66.3B | $68.5B |
| Q4 2025 | Feb 5, 2026 | $7.88 | $8.08 | 2.53% | $70.3B | $72.5B |
| Q3 2025 | Oct 30, 2025 | $7.64 | $7.83 | 2.49% | $67.6B | $69.6B |
| Q2 2025 | Jul 31, 2025 | $7.16 | $7.20 | 0.62% | $62.9B | $67.1B |
| Q1 2025 | May 2, 2025 | $6.35 | $6.74 | 6.12% | $59.9B | $65.5B |
| Q4 2024 | Jan 30, 2025 | $7.83 | $6.64 | -15.17% | $63.7B | $65.7B |
| Q3 2024 | Oct 31, 2024 | $7.23 | $7.51 | 3.91% | $59.7B | $63.7B |
| Q2 2024 | Aug 1, 2024 | $6.43 | $6.72 | 4.49% | $58.3B | $60.5B |
| Q1 2024 | May 2, 2024 | $6.22 | $6.47 | 4.02% | $56.6B | $57.2B |
| Q4 2023 | Feb 2, 2024 | $6.54 | $6.79 | 3.86% | $48.9B | $51.1B |
| Q3 2023 | Nov 2, 2023 | $6.68 | $6.77 | 1.35% | $48.1B | $49.1B |
| Q2 2023 | Aug 3, 2023 | $6.03 | $6.13 | 1.65% | $47.2B | $48.6B |
| Q1 2023 | May 5, 2023 | $5.26 | $5.41 | 2.86% | $45.6B | $46.5B |
| Q4 2022 | Feb 3, 2023 | $4.86 | $4.96 | 1.96% | $45.9B | $45.7B |
| Q3 2022 | Nov 3, 2022 | $5.72 | $6.04 | 5.67% | $44.8B | $45.4B |
| Q2 2022 | Aug 4, 2022 | $5.49 | $6.22 | 13.35% | $44.5B | $45.4B |
| Q1 2022 | May 6, 2022 | $5.18 | $6.01 | 15.97% | $43.4B | $44.1B |
| Q4 2021 | Feb 3, 2022 | $4.72 | $4.77 | 0.98% | $43.9B | $45.7B |
| Q3 2021 | Nov 4, 2021 | $5.22 | $5.73 | 9.68% | $42.9B | $44.3B |

## Frequently Asked Questions

### When did The Cigna (CI) last report earnings?

The Cigna last reported on Jul 30, 2026, covering fiscal Q2 2026.

### Did CI beat earnings estimates?

Yes. The Cigna reported EPS of $7.78 for Q2 2026 against a $7.60 estimate — a 2.42% beat.

### How much revenue did CI report last quarter?

The Cigna reported $71.7B in revenue for Q2 2026, against a consensus estimate of $70.1B.

## Similar Stocks

- [CNC](https://www.lighthorse.io/tickers/cnc) — Centene Corporation Common Stock
- [HUM](https://www.lighthorse.io/tickers/hum) — Humana Inc. Common Stock
- [UNH](https://www.lighthorse.io/tickers/unh) — UnitedHealth Group Incorporated Common Stock (DE)
- [HCA](https://www.lighthorse.io/tickers/hca) — HCA Healthcare, Inc. Common Stock
- [ELV](https://www.lighthorse.io/tickers/elv) — Elevance Health, Inc. Common Stock
- [CVS](https://www.lighthorse.io/tickers/cvs) — CVS Health Corporation Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).